Biotech News
Fennec Pharmaceuticals to Report First Quarter 2026 Financial Results on May 14, 2026
investors.fennecpharma.com2026-05-07 10:46 EST
RESEARCH TRIANGLE PARK, N.C., May 07, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release its first quarter 2026 financial results before the opening of the U.S.